News
There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.
THE primary purpose of this report is to emphasize the relation of a high-pitched "squeaking" or "musical" systolic murmur to aortic stenosis and calcification of the aortic valve. This is not so ...
A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...
BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...
10d
Bangkok Post on MSNAortic Valve Stenosis: A Silent, Deadly ThreatAortic valve stenosis” is an often-overlooked condition and a growing health concern in ageing societies such as Thailand.
12d
MedPage Today on MSNEvolut Low Risk TAVR Still Chugging Along, Now Halfway to Trial's Finish LineCHICAGO -- Transcatheter aortic valve replacement (TAVR) continued to hold its own against surgery for younger patients at ...
Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...
With surveillance, conversion to acute valve syndrome happened frequently and was linked to worse clinical outcomes.
Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter aortic valve replacement (TAVR) had similar rates of death or disabling ...
Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...
JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results